Segluromet Europäische Union - Deutsch - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Pantoprazol NYC 40 mg Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

pantoprazol nyc 40 mg

takeda gmbh (8156606) - pantoprazol-natrium 1.5 h<2>o - magensaftresistente tablette - teil 1 - magensaftresistente tablette; pantoprazol-natrium 1.5 h<2>o (24848) 45,1 milligramm

Pantozol 40mg Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

pantozol 40mg

takeda gmbh (8156606) - pantoprazol-natrium 1.5 h<2>o - magensaftresistente tablette - teil 1 - magensaftresistente tablette; pantoprazol-natrium 1.5 h<2>o (24848) 45,1 milligramm

Rifun 40mg Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rifun 40mg

takeda gmbh (8156606) - pantoprazol-natrium 1.5 h<2>o - magensaftresistente tablette - pantoprazol-natrium 1.5 h<2>o (24848) 45,1 milligramm

Eucreas Europäische Union - Deutsch - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Europäische Union - Deutsch - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).

Steglujan Europäische Union - Deutsch - EMA (European Medicines Agency)

steglujan

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic säure, sitagliptin phosphat monohydrat - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - steglujan ist indiziert bei erwachsenen im alter von 18 jahren und älter mit typ-2-diabetes mellitus als ergänzung zu diät und bewegung zur verbesserung der glykämischen kontrolle:wenn metformin und/oder einem sulphonylurea (su) und eine der monocomponents von steglujan bieten keine adäquaten glykämischen kontrolle. in patienten, die bereits behandelt mit der kombination von ertugliflozin and sitagliptin als separate tabletten.

Xylometazolin/Dexpanthenol Teva 0,5 mg/ml + 50 mg/ml Nasenspray, Lösung Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

xylometazolin/dexpanthenol teva 0,5 mg/ml + 50 mg/ml nasenspray, lösung

teva b.v. beiname: teva generics (8157681) - xylometazolinhydrochlorid; dexpanthenol - nasenspray, lösung - 0,5 mg/ml + 50 mg/ml - teil 1 - nasenspray, lösung; xylometazolinhydrochlorid (06397) 0,5 milligramm; dexpanthenol (00841) 50 milligramm

Xylometazolin/Dexpanthenol Teva 0,5 mg/ml + 50 mg/ml Nasenspray, Lösung Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

xylometazolin/dexpanthenol teva 0,5 mg/ml + 50 mg/ml nasenspray, lösung

teva b.v. beiname: teva generics (8157681) - xylometazolinhydrochlorid; dexpanthenol - nasenspray, lösung - 0,5 mg/ml + 50 mg/ml - teil 1 - nasenspray, lösung; xylometazolinhydrochlorid (06397) 0,5 milligramm; dexpanthenol (00841) 50 milligramm

Xylometazolin/Dexpanthenol Teva 1 mg/ml + 50 mg/ml Nasenspray, Lösung Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

xylometazolin/dexpanthenol teva 1 mg/ml + 50 mg/ml nasenspray, lösung

teva b.v. beiname: teva generics (8157681) - xylometazolinhydrochlorid; dexpanthenol - nasenspray, lösung - 1 mg/ml + 50 mg/ml - teil 1 - nasenspray, lösung; xylometazolinhydrochlorid (06397) 1 milligramm; dexpanthenol (00841) 50 milligramm